POZN Share Price

Open 6.35 Change Price %
High 6.46 1 Day -0.43 -6.75
Low 5.72 1 Week 0.00 0.00
Close 5.94 1 Month 0.00 0.00
Volume 1384637 1 Year 0.00 0.00
52 Week High 47.24
52 Week Low 30.49
POZN Important Levels
Resistance 2 6.63
Resistance 1 6.34
Pivot 6.04
Support 1 5.54
Support 2 5.25
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.22 37.50%
FNFG 10.18 -0.20%
AVEO 1.95 56.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
More..
NASDAQ USA Top Gainers Stocks
AVEO 1.95 56.00%
LOCM 0.09 50.00%
DCTH 0.22 37.50%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
OPXAW 0.15 25.00%
PTSX 0.15 25.00%
FRED 12.61 23.02%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Pozen, Inc. (NASDAQ: POZN)

POZN Technical Analysis 5
As on 5th Feb 2016 POZN Share Price closed @ 5.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.96 & Strong Sell for SHORT-TERM with Stoploss of 6.74 we also expect STOCK to react on Following IMPORTANT LEVELS.
POZN Target for June
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
POZN Other Details
Segment EQ
Market Capital 170625984.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.pozen.com
POZN Address
POZN
1414 Raleigh Road
Suite 400
Chapel Hill, NC 27517
United States
Phone: 919-913-1030
Fax: 919-913-1039
POZN Latest News
Interactive Technical Analysis Chart Pozen, Inc. ( POZN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pozen, Inc.
POZN Business Profile
POZEN Inc. (POZEN), is a pharmaceutical company focused on transforming medicine. The Company had developed Treximet in collaboration with GlaxoSmithKline (GSK). Treximet is the brand name for the product combining sumatriptan 85 milligram, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet designed for the acute treatment of migraine. The Company has developed VIMOVO with AstraZeneca AB (AstraZeneca). VIMOVO is the brand name for a fixed dose combination of the proton pump inhibitor (PPI) esomeprazole magnesium with the non-steroidal anti-inflammatory drug (NSAID) naproxen in a single tablet. On November 23, 2011, the Company entered into a Purchase and Sale Agreement with CPPIB Credit Investments Inc (CII,), pursuant to which it sold, and CII purchased, its right to receive future royalty payments arising from United States sales of MT 400, including Treximet.